Quantcast

Latest Pharmacology Stories

2014-10-20 20:24:32

LONDON, Oct. 20, 2014 /PRNewswire/ -- Future Prospects for Leading Companies Report DetailsDermatological drugs - new study showing you trends, R&D progress, and predicted revenuesWhere's the dermatological drugs market heading? Visiongain's brand new report shows you potential revenues to 2024, assessing data, trends, opportunities and prospects there.Our 272-page report provides 169 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future...

2014-10-20 20:24:18

LONDON, Oct. 20, 2014 /PRNewswire/ -- Report DetailsPre-filled syringes and related devices - discover leading companies' revenue prospectsHow are companies in the pre-filled syringe industry performing? Visiongain's report gives you data, analysis and discussions for producers of those drug delivery devices.Our updated study lets you assess companies in the pre-filled (ready-to-fill) syringe industry and market, showing you their prospects to 2024. There you see financial results,...

2014-10-20 16:26:31

USA MedicalCard Free Pharmacy Discount Card Can Save Consumers Up To 75% Off Brand-Name Drugs and Generics Every Day MIRAMAR BEACH, Fla., Oct. 20, 2014 /PRNewswire/ -- USA MedicalCard announces plans to expand the national mailing of its free pharmacy discount card that can save consumers up to 75% off brand-name drugs and generics. The company would like to ensure the cards reach people with the most significant need and is focused on providing savings on almost all...

2014-10-20 16:26:25

Ophthotech/Novartis's Fovista Will Exceed $500 Million in 2023 Sales as a Treatment for the Wet Form of the Disease, According to Findings from Decision Resources Group BURLINGTON, Mass., Oct. 20, 2014 /PRNewswire/ -- Decision Resources Group finds that the market for age-related macular degeneration (AMD) pharmacotherapies will expand 6 percent annually to reach nearly $9 billion in 2023 in the G7 pharmaceutical markets (United States, France, Germany, Italy, Spain, the United Kingdom and...

2014-10-20 08:39:37

Company Will Share Report Findings Each Quarter to Track Industry Trends FAIR LAWN, N.J., Oct. 20, 2014 /PRNewswire/ -- AnythingIT/WeedHire (OTCBB: ANYI) today announced the findings of WeedHire's Third Quarter 2014 Cannabis Jobs Report, the industry authority on employment trends in the legal marijuana industry. The findings of the Third Quarter 2014 Cannabis Jobs Report show significant demand by state governments looking to fill regulatory and other positions, including senior...

2014-10-20 08:34:56

LOGIC's New "Closed System" Vaporizer Smokes the Competition at NACS Show POMPANO BEACH, Fla., Oct. 20, 2014 /PRNewswire/ -- LOGIC Technology, a leading electronic cigarette company in the United States, is charging up the competition with the launch of their new LOGIC PRO Advanced Vapor Systems, the first-of-its-kind "closed-system" vaporizing device ever to hit the market. LOGIC PRO Advanced Vapor Systems work in conjunction with revolutionary pre-filled, sealed eLiquid capsules...

2014-10-20 08:33:33

LONDON, October 20, 2014 /PRNewswire/ -- Richmond Pharmacology has extended its capacity with an additional six-bed facility dedicated to screening and out-patient procedures for early phase studies in patients, complementing its existing 68-bed facility within Croydon University Hospital. (Photo: http://photos.prnewswire.com/prnh/20141013/709417-a ) (Photo: http://photos.prnewswire.com/prnh/20141013/709417-b ) The new facility is adaptable to...

2014-10-20 08:32:49

AACHEN, Germany, October 20, 2014 /PRNewswire/ -- Sascha Becker will be appointed to the Executive Board of the pharmaceutical company Gruenenthal and take over the finance unit as Group Chief Financial Officer in the first quarter of 2015. Since 2003, Sascha Becker (43) has been working for Merck and is currently CFO of the biopharmaceutical division of Merck Serono with an annual turnover of 6.3 million Euros and is responsible for 10,000 employees. At Gruenenthal, he will...

2014-10-20 08:32:21

Expands rHuPH20 Production SAN DIEGO, Oct. 20, 2014 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that the U.S. Food and Drug Administration (FDA) has approved new contract manufacturing facilities used in the production of Hylenex(®) recombinant (hyaluronidase human injection). The FDA approved the use of the Cook Pharmica manufacturing facility in Bloomington, Indiana for the production of bulk rHuPH20, the active ingredient used in Hylenex, and the...

2014-10-20 08:31:47

ALBANY, N.Y., Oct. 20, 2014 /PRNewswire/ -- Pharmaceutic Labs announces the opening of its specialty CGMP pharmaceutical outsourcing facility in Albany, NY for admixing, compounding, drug shortages and clinical studies and trials. The company meets and/or exceeds the FDA standards for safety and quality, using 21 CFR Part 210 and 21 CFR Part 211. The 10,000 square foot outsourcing facility was designed to provide the highest levels of quality assurance and quality control. The...


Latest Pharmacology Reference Libraries

Pharmacophobia
2013-12-24 12:55:45

Pharmacophobia or medication phobia, comes from Greek pharmakon, meaning “drug, medicine” and phobos, meaning “fear”, is the fear of the use of pharmacological treatments. In severe, excessive, and irrational cases, it might be a type of specific phobia. While lack of awareness by patient of adverse drug reactions can have a serious consequence, having a phobia of medications can also have serious detrimental effects on the patient’s health. Medication phobia can also lead to...

Generalized Anxiety Disorder
2013-07-25 15:07:54

Generalized Anxiety Disorder (GAD) is an anxiety disorder with worry about normal, everyday situations such as finance, health and wellbeing in relationships (personal and work related) all lasting longer than six months. Symptoms The symptoms of GAD can include but are not limited to difficulty swallowing, rashes, shortness of breath, fidgeting, headaches, tension, nausea, etc. In order for GAD to be ruled as present, the symptoms and feelings must be experiences for at least six...

European Journal of Medical Chemistry
2012-05-12 22:03:06

The European Journal of Medical Chemistry is a peer-reviewed scientific journal for medical chemistry. It is published by Elsevier. It was established in 1966 under the title Chimica Therapeutica. That name was maintained until 1973. Even after changing to its current name in 1974, the journal was still subtitled Chimica Therapeutica until 1981; from 1982 to 1986 it was subtitled Chimie Therapeutique, indicating its French origin. The Journal publishes studies on all aspects of medicinal...

0_3ff7149ca288229c28bcd855846ea8c7
2009-04-28 16:00:11

Bursera graveolens or Palo Santo is a tree indigenous to South America in Argetina, Paraguay, Boliva and coastal areas of Ecuador. Palo Santo means "holy wood" in English and belongs in the same family as frankincense and myrrh. Although it has been used in homeopathic medicine for years, most recently it is the extraction of essential oils that has put this plant in the spotlight. Limonene, a-Terpineol, Menthofuran and Carvone are a few of the oils derived from this plant. Native...

31_c737ff73aa3c47be364b2a8cce214e0c
2005-07-12 18:32:21

Datura wrightii (a poisonous weed) is sometimes used as a hallucinogen. It is commonly called Sacred Datura. Datura wrightii is classified as a deliriant, or an anticholinergic. In the US it is, however, called Western Jimson Weed.

More Articles (5 articles) »
Word of the Day
abrosia
  • Wasting away as a result of abstinence from food.
The word 'abrosia' comes from a Greek roots meaning 'not' and 'eating'.